BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog]. 1985

N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth

The antiarrhythmic action of GS 015 was studied in proportion to its plasma concentrations ascertained in parallel, making use of the model of the two-step coronary ligature in the conscious dog. Blood levels of 1.0 microgram/ml (2 mg/kg i.v.) or of 0.8 microgram/ml (5 mg/kg orally) brought about a complete suppression of ectopic arrhythmias. The limit concentration for this effect is about 0.5 microgram/ml.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Pharmacokinetics and metabolism of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the rat].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Antifibrillatory and anti-arrhythmic action of 3-carbethoxyamino-5-dimethylamino-acetyl iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on models of myocardial ischemia].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Pharmacologic studies on the effect of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on the vegetative and central nervous system].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Synthesis of 3-carbethoxyamino-5-dimethylamino-[1-14C]-acetyl- 10,11-dihydro-5h-dibenz[b,f]azepine hydrochloride (Bonnecor, AWD 19-166, GS 015)].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Summarized presentation of studies on the toxicology of 3-carbethoxyamino-5-dimethylamino-acetyl-10,11- dihydrobenz[b,f]azepine hydrochloride (Bonnecor, GS 015, AWD 19-166)].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Characteristics of the anti-arrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-imino-dibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015)].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Clinico-electrophysiologic studies on the action of the anti-arrhythmic substance 3-carbethoxyamino-5-dimethylamino-acetyl-10,11-dihydro-5H- dibenz[b,f]azepine hydrochloride (Bonnecor, AWD 19-166, GS 015)].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Pharmaceutical characterization and spectroscopy of Bonnecor (AWD 19-166, GS 015)].
December 1985, Die Pharmazie,
N V Kaverina, and A P Rodionov, and V V Lyskovzev, and J K Grigoreva, and M T Sulakvelidze, and H Poppe, and W Klemm, and U Morgenroth
[Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
December 1985, Die Pharmazie,
Copied contents to your clipboard!